54 results
F-1
EX-3.1
KZIA
Kazia Therapeutics Limited
31 Jan 24
Registration statement (foreign)
12:00am
of its intention to make the payment.
Reimbursement is a debt due
6.15
The obligation of the Member to reimburse the Company under clause 6.13 … is a debt due to the Company as if it were a call on all the Member’s shares, duly made at the time when the written demand for reimbursement is given
6-K
EX-4.2
KZIA
Kazia Therapeutics Limited
6 Dec 23
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
8:31am
the remainder of such provisions or the remaining provisions of this Warrant.
n) Expense Reimbursement. The Holder shall be reimbursed by the Company
6-K
EX-4.3
KZIA
Kazia Therapeutics Limited
6 Dec 23
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
8:31am
or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.
n) Expense Reimbursement. The Holder shall
6-K
EX-4.1
KZIA
Kazia Therapeutics Limited
6 Dec 23
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
8:31am
Reimbursement. The Holder shall be reimbursed by the Company for any fees charged to the Holder by the Depositary in connection with the issuance or holding
6-K
EX-10.1
KZIA
Kazia Therapeutics Limited
6 Dec 23
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
8:31am
or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement
6-K
EX-99.1
0olaihc
5 Sep 23
Current report (foreign)
7:02am
6-K
llsgcovo58o4wi2ckp
5 Jul 19
Current report (foreign)
6:31am